First Manhattan’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.96M Sell
6,653
-256
-4% -$76K 0.01% 352
2025
Q4
$1.89M Sell
6,909
-213
-3% -$57.9K 0.01% 348
2025
Q3
$1.92M Buy
7,122
+325
+5% +$88.4K 0.01% 339
2025
Q2
$1.87M Sell
6,797
-631
-8% -$172K 0.01% 332
2025
Q1
$1.97M Sell
7,428
-95
-1% -$23.4K 0.01% 303
2024
Q4
$1.79M Buy
7,523
+842
+13% +$194K 0.01% 315
2024
Q3
$1.47M Sell
6,681
-130
-2% -$26.9K ﹤0.01% 326
2024
Q2
$1.34M Sell
6,811
-1,439
-17% -$297K ﹤0.01% 327
2024
Q1
$1.78M Sell
8,250
-379
-4% -$79.6K 0.01% 307
2023
Q4
$1.82M Sell
8,629
-443
-5% -$94.5K 0.01% 309
2023
Q3
$1.82M Sell
9,072
-372
-4% -$73.9K 0.01% 316
2023
Q2
$1.75M Buy
9,444
+35
+0.4% +$6.47K 0.01% 320
2023
Q1
$1.8M Buy
9,409
+3,902
+71% +$706K 0.01% 332
2022
Q4
$926K Sell
5,507
-149,958
-96% -$26.1M ﹤0.01% 423
2022
Q3
$27.5M Sell
155,465
-5,313
-3% -$1.05M 0.12% 78
2022
Q2
$32.9M Sell
160,778
-6,505
-4% -$1.38M 0.13% 74
2022
Q1
$39.8M Sell
167,283
-2,221
-1% -$522K 0.13% 73
2021
Q4
$38.7M Sell
169,504
-7,944
-4% -$1.75M 0.13% 72
2021
Q3
$34.3M Sell
177,448
-16,460
-8% -$3.33M 0.13% 76
2021
Q2
$41.2M Sell
193,908
-2,707
-1% -$572K 0.15% 73
2021
Q1
$40.2M Sell
196,615
-5,034
-2% -$992K 0.17% 74
2020
Q4
$36.7M Sell
201,649
-31,916
-14% -$5.43M 0.18% 73
2020
Q3
$39.1M Sell
233,565
-7,303
-3% -$1.23M 0.2% 67
2020
Q2
$39.2M Sell
240,868
-5,939
-2% -$1.06M 0.23% 64
2020
Q1
$42.7M Buy
246,807
+28,989
+13% +$5.77M 0.28% 54
2019
Q4
$43.7M Buy
217,818
+27,485
+14% +$5.64M 0.22% 69
2019
Q3
$40.2M Buy
190,333
+57,255
+43% +$12M 0.22% 71
2019
Q2
$25.8M Buy
133,078
+116,595
+707% +$21.5M 0.14% 96
2019
Q1
$2.71M Buy
16,483
+252
+2% +$44.6K 0.02% 300
2018
Q4
$3.05M Hold
16,231
0.02% 290
2018
Q3
$2.76M Hold
16,231
0.01% 330
2018
Q2
$2.66M Hold
16,231
0.02% 325
2018
Q1
$2.63M Hold
16,231
0.01% 323
2017
Q4
$2.37M Buy
16,231
+1
+0% +$142 0.01% 355
2017
Q3
$2.2M Hold
16,230
0.01% 355
2017
Q2
$2.03M Sell
16,230
-35
-0.2% -$4.19K 0.01% 353
2017
Q1
$1.93M Buy
16,265
+35
+0.2% +$4.21K 0.01% 358
2016
Q4
$1.87M Hold
16,230
0.01% 348
2016
Q3
$1.7M Hold
16,230
0.01% 356
2016
Q2
$1.58M Sell
16,230
-650
-4% -$61.4K 0.01% 366
2016
Q1
$1.62M Sell
16,880
-3,300
-16% -$300K 0.01% 357
2015
Q4
$1.83M Sell
20,180
-164
-0.8% -$15.4K 0.01% 358
2015
Q3
$1.89M Hold
20,344
0.01% 345
2015
Q2
$1.89M Hold
20,344
0.01% 354
2015
Q1
$1.93M Hold
20,344
0.01% 349
2014
Q4
$1.8M Hold
20,344
0.01% 355
2014
Q3
$1.63M Buy
20,344
+164
+0.8% +$12.4K 0.01% 365
2014
Q2
$1.43M Hold
20,180
0.01% 370
2014
Q1
$1.49M Sell
20,180
-3,250
-14% -$245K 0.01% 364
2013
Q4
$1.84M Hold
23,430
0.01% 342
2013
Q3
$1.73M Hold
23,430
0.01% 350
2013
Q2
$1.74M Buy
+23,430
New +$1.54M 0.01% 343

Other funds holding CME

First Manhattan's CME Position: Q1 2026 in Review

First Manhattan reduced its CME Group (CME) stake by 3.7% in Q1 2026, selling an estimated $76K and leaving 6,653 shares worth $1.96M. The position accounts for 0.01% of the portfolio, ranked #352.

First Manhattan first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $43.7M in Q4 2019. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • First Manhattan held 6,653 shares of CME Group worth $1.96M as of Q1 2026.
  • First Manhattan sold 256 CME Group shares in Q1 2026, an estimated $76K.
  • CME Group made up 0.01% of First Manhattan's portfolio in Q1 2026, its #352 holding.
  • First Manhattan first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • First Manhattan's CME Group position peaked at $43.7M in Q4 2019.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.